Literature DB >> 12889566

Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis.

A Comlekci1, H Akpinar, S Yesil, I Okan, E Ellidokuz, A Okan, G Ersoz, E Tankurt, Y Batur.   

Abstract

BACKGROUND: The aim of the present study was to investigate serum leptin levels in relation to anthropometric features in patients with liver cirrhosis (LC) and chronic viral hepatitis (CVH), and to determine the effect of the severity and aetiology of the LC on serum leptin levels.
METHODS: Forty-nine patients with LC, 32 patients with CVH and 69 control subjects were age, body mass index (BMI) and sex-matched and included in the study. Plasma glucose, serum leptin and insulin levels were determined. Insulin resistance was assessed using homoeostasis model assessment (HOMA). Body composition was estimated by skinfold thickness.
RESULTS: Female patients with Child-A LC had higher levels of leptin, and female and male patients with Child-A LC had higher absolute leptin (leptin/BFM) levels compared to patients with Child-C LC and control subjects. Serum leptin levels of the patients with alcohol LC were higher than the control subjects, but the absolute leptin levels were comparable. When alcoholic and post-viral hepatitis cirrhotic patients were compared with each other on an aetiologic basis, there was no significant difference between them in leptin and absolute leptin levels. There were significant correlations between leptin and BMI, body fat percentage (BFP), BFM (body fat mass) in all three groups in both sexes.
CONCLUSIONS: These data suggest that the physiologic correlations among serum leptin level, sex, BMI and BFM were well preserved in patients with chronic liver disease. Patients with alcohol LC had higher leptin levels. In early stages of liver disease, leptin levels and absolute leptin levels are higher than in normal subjects. However, in advanced stages of the disease the significant decline in leptin levels and similar levels of leptin expressed in relation to BFM compared to control subjects predominantly represent the expression of fat mass.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889566     DOI: 10.1080/00365520310003877

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

Review 1.  Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?

Authors:  Sotirios K Bethanis; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

2.  Repeated whiskey binges promote liver injury in rats fed a choline-deficient diet.

Authors:  Natalia Nieto; Marcos Rojkind
Journal:  J Hepatol       Date:  2006-11-02       Impact factor: 25.083

3.  Primary study of leptin and human hepatocellular carcinoma in vitro.

Authors:  Jing Zhou; Wei Lei; Lei Shen; He-Sheng Luo; Zhi-Xiang Shen
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

4.  Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta.

Authors:  Komal Ramani; Heping Yang; Meng Xia; Ainhoa Iglesias Ara; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

5.  Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.

Authors:  Tarek E Korah; Sawsan El-Sayed; Maathir K Elshafie; Ghada E Hammoda; Manal A Safan
Journal:  World J Hepatol       Date:  2013-02-27

6.  The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection.

Authors:  Huseyin Ataseven; Ibrahim Halil Bahcecioglu; Nalan Kuzu; Mehmet Yalniz; Selman Celebi; Ahmet Erensoy; Bilal Ustundag
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 7.  Adipokines in Liver Cirrhosis.

Authors:  Christa Buechler; Elisabeth M Haberl; Lisa Rein-Fischboeck; Charalampos Aslanidis
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

8.  An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.

Authors:  Spilios Manolakopoulos; Sotirios Bethanis; Charis Liapi; Fotini Stripeli; Pantelis Sklavos; Alexandra Margeli; Aggeliki Christidou; Aggeliki Katsanika; Evangellos Vogiatzakis; Dimitrios Tzourmakliotis; Stamatios Theocharis
Journal:  BMC Gastroenterol       Date:  2007-05-31       Impact factor: 3.067

Review 9.  Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease.

Authors:  Eunha Chang; Jae Seung Chang; In Deok Kong; Soon Koo Baik; Moon Young Kim; Kyu-Sang Park
Journal:  Gut Liver       Date:  2022-03-15       Impact factor: 4.519

10.  Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Qing Lu; Yan-Rong Lu; Jie Zhang; Yan Liu; Wen-Dong Wang
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.